GB1067742A - Process for the preparation of l-ornithine l-aspartate - Google Patents

Process for the preparation of l-ornithine l-aspartate

Info

Publication number
GB1067742A
GB1067742A GB3640563A GB3640563A GB1067742A GB 1067742 A GB1067742 A GB 1067742A GB 3640563 A GB3640563 A GB 3640563A GB 3640563 A GB3640563 A GB 3640563A GB 1067742 A GB1067742 A GB 1067742A
Authority
GB
United Kingdom
Prior art keywords
ornithine
aspartate
solvent
volume
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3640563A
Inventor
Hirofuto Marumo
Kunio Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to GB3640563A priority Critical patent/GB1067742A/en
Publication of GB1067742A publication Critical patent/GB1067742A/en
Expired legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Crystalline L-ornithine L-aspartate monohydrate is prepared by adding to an aqueous solution of L-ornithine L-aspartate a water-miscible organic solvent which is a non-solvent for L-ornithine L-aspartate, a volume of non-solvent of at least one-fifth, based on the volume of the solution, being added initially and, after the addition of seed crystals, a further volume of at least one-fifth being added at a rate such that at least 30 hours would be required to add the same volume of non-solvent as of the original solution.
GB3640563A 1963-09-16 1963-09-16 Process for the preparation of l-ornithine l-aspartate Expired GB1067742A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3640563A GB1067742A (en) 1963-09-16 1963-09-16 Process for the preparation of l-ornithine l-aspartate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3640563A GB1067742A (en) 1963-09-16 1963-09-16 Process for the preparation of l-ornithine l-aspartate

Publications (1)

Publication Number Publication Date
GB1067742A true GB1067742A (en) 1967-05-03

Family

ID=10387837

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3640563A Expired GB1067742A (en) 1963-09-16 1963-09-16 Process for the preparation of l-ornithine l-aspartate

Country Status (1)

Country Link
GB (1) GB1067742A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447366A (en) * 1980-12-04 1984-05-08 Morelle Jean V Derivatives of lysine and aspartic acid
EP0477991A1 (en) * 1990-09-28 1992-04-01 Kyowa Hakko Kogyo Co., Ltd. Process for producing crystals of salt of acidic amino acid and basic amino acid
US8173706B2 (en) 2009-04-03 2012-05-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
CN102827017A (en) * 2011-06-14 2012-12-19 上海励睿化学科技有限公司 Crystal form of double salt compound and preparation method thereof
US8389576B2 (en) 2004-11-26 2013-03-05 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US8946473B2 (en) 2010-10-06 2015-02-03 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
US10039735B2 (en) 2014-11-24 2018-08-07 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
US11066352B2 (en) 2017-05-11 2021-07-20 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
US11266620B2 (en) 2009-06-08 2022-03-08 Ucl Business Ltd Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
CN114349652A (en) * 2021-12-10 2022-04-15 汕头市佳禾生物科技有限公司 Preparation method of L-lysine aspartate

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447366A (en) * 1980-12-04 1984-05-08 Morelle Jean V Derivatives of lysine and aspartic acid
EP0477991A1 (en) * 1990-09-28 1992-04-01 Kyowa Hakko Kogyo Co., Ltd. Process for producing crystals of salt of acidic amino acid and basic amino acid
US10610506B2 (en) 2004-11-26 2020-04-07 Ucl Business Ltd Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US9566257B2 (en) 2004-11-26 2017-02-14 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US8389576B2 (en) 2004-11-26 2013-03-05 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US9604909B2 (en) 2009-04-03 2017-03-28 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US8492439B2 (en) 2009-04-03 2013-07-23 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US8785498B2 (en) 2009-04-03 2014-07-22 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US9034925B2 (en) 2009-04-03 2015-05-19 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US10550069B2 (en) 2009-04-03 2020-02-04 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US11161802B2 (en) 2009-04-03 2021-11-02 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US10173964B2 (en) 2009-04-03 2019-01-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US8173706B2 (en) 2009-04-03 2012-05-08 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
US11266620B2 (en) 2009-06-08 2022-03-08 Ucl Business Ltd Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
US8946473B2 (en) 2010-10-06 2015-02-03 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
US9260379B2 (en) 2010-10-06 2016-02-16 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
CN102827017B (en) * 2011-06-14 2014-07-02 上海励睿化学科技有限公司 Crystal form of double salt compound and preparation method thereof
CN102827017A (en) * 2011-06-14 2012-12-19 上海励睿化学科技有限公司 Crystal form of double salt compound and preparation method thereof
US10525029B2 (en) 2014-11-24 2020-01-07 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US11040021B2 (en) 2014-11-24 2021-06-22 Ucl Business Ltd Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10039735B2 (en) 2014-11-24 2018-08-07 Ucl Business Plc Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
US10835506B2 (en) 2015-08-18 2020-11-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
US11066352B2 (en) 2017-05-11 2021-07-20 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
CN114349652A (en) * 2021-12-10 2022-04-15 汕头市佳禾生物科技有限公司 Preparation method of L-lysine aspartate
CN114349652B (en) * 2021-12-10 2024-03-29 汕头市佳禾生物科技有限公司 Preparation method of L-lysine aspartate

Similar Documents

Publication Publication Date Title
GB1067742A (en) Process for the preparation of l-ornithine l-aspartate
GB1416365A (en) Process for the manufacture of drystalline ammonium phosphates
ES470392A1 (en) Crystallization process for cefazolin sodium
ES282218A1 (en) A procedure to produce the hydrofuside acid compound (Machine-translation by Google Translate, not legally binding)
ES304521A1 (en) Procedure for the preparation of salts from fusºdic acid with antibiotics of the tetracycline series (Machine-translation by Google Translate, not legally binding)
ES309611A1 (en) Procedure for the preparation of lincomicina b. (Machine-translation by Google Translate, not legally binding)
GB862159A (en) Potassium phenoxymethyl penicillin
GB1001712A (en) A process for the preparation of 2,3-dicyano-5,6-dibromo-benzoquinone and this compound when thus prepared
CA615069A (en) Process of preparing compound fertilizer
GB922378A (en) Thiolo- and selenolo-phosphoric, -thionophosphoric, -phosphonic and -thionophosphonic acid esters
GB856393A (en) A process for the manufacture of 4-amino-isoxazolidone-(3)
CA587378A (en) Process for the preparation of common salt by the evaporation of solutions
CA580442A (en) Basically substituted phenylhydrazones, the acid addition salts thereof and process of preparing these compounds
GB602078A (en) Manufacture of stable supersaturated solutions of saccharide derivatives of compounds of the suprarenal cortex hormone series
ES259584A1 (en) Procedure for the preparation of piridoxalderivados (Machine-translation by Google Translate, not legally binding)
GB854140A (en) Improvements in and relating to the production of n-carboxy-alpha-amino acid anhydrides
CA588865A (en) Process for the production of organic hydroxylamine compounds
CA593107A (en) Process for the preparation of salts of dithiocarbamic acids, showing a low water solubility
CA589407A (en) Generator mount for farm tractor
CA532828A (en) Apparatus for producing articles as by compound rotation of article-forming means
ES230498A1 (en) A method of preparation for derivation of organic compounds difficult reagents (Machine-translation by Google Translate, not legally binding)
CA588687A (en) Process for producing organic sulfonic acids
AU263950B2 (en) Method for preparing organic compounds
ES265292A1 (en) Procedure for preparing 4-hydroxy-3-ceto-4-androsteno (Machine-translation by Google Translate, not legally binding)
AU237089B2 (en) Process for preparing phthaulic acid derivatives